BioSpace News Archive

BioCapital

Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency

Emergent BioSolutions Inc. announced NARCAN® Naloxone HCl Nasal Spray 4 mg will be available on shelves nationwide and online beginning in September.

August 30, 2023
·
8 min read
Genetown

CHU Bordeaux is live on SOPHiA GENETICS

SOPHiA GENETICS announced that CHU Bordeaux, a full-service hospital servicing the population of Bordeaux and the surrounding area, has completed implementation of the SOPHiA DDM™ Platform into its organization.

August 30, 2023
·
4 min read
Genetown

Oculis to Present at Upcoming September 2023 Investor Conferences

Oculis Holding AG announced that Riad Sherif, MD, Chief Executive Officer, and Sylvia Cheung, Chief Financial Officer will be attending and presenting at the following upcoming investor conferences:

August 30, 2023
·
2 min read
Genetown

Karuna Therapeutics to Present at Upcoming September 2023 Investor Conferences

Karuna Therapeutics, Inc. announced that management will present at the following upcoming investor conferences.

August 30, 2023
·
1 min read
Pharm Country

Eagle Pharmaceuticals to Present BYFAVO® (remimazolam) for Injection Abstract at Prestigious Society for Neuroscience in Anesthesiology and Critical Care (SNACC) Conference

Eagle Pharmaceuticals, Inc. announced that it has been selected to present a platform presentation at the Society for Neuroscience in Anesthesiology and Critical Care Annual Meeting being held September 8-10, 2023, in Alexandria, VA.

August 30, 2023
·
11 min read
Business

Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation

Johnson & Johnson announced updates to its financials and 2023 guidance which reflect its operations as a company focused on transformational innovation in Pharmaceutical and MedTech.

August 30, 2023
·
10 min read
Genetown

EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences - August 30, 2023

EyePoint Pharmaceuticals, Inc., a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, announced that the Company will participate at the following upcoming conferences.

August 30, 2023
·
1 min read
Policy

Zealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinism

Zealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinism.

August 30, 2023
·
10 min read
Policy

Outlook Therapeutics® Provides Regulatory Update on FDA Review of ONS-5010 / LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD

Outlook Therapeutics, Inc. announced the U.S. Food and Drug Administration has issued a CRL to the Company’s BLA for ONS-5010, an investigational ophthalmic formulation of bevacizumab under development to treat wet AMD.

August 30, 2023
·
7 min read
Business

Immunovia Publishes Interim Report for January-June 2023

As announced in July, we are significantly restructuring Immunovia to focus on our novel next-generation test for detection of pancreatic cancer.

August 30, 2023
·
9 min read